ReviewCancers2024

Novel Targeted Agents in Advanced and Recurrent Low-Grade Serous Ovarian Cancer: A Silver Lining in the Therapy of a Chemoresistant Disease?

Arina Onoprienko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.